×

Europe

f9a57bfe-51c7-11e9-8939-5623721d3707

Europe’s pragmatic approach to clinical evidence for legacy devices – or why the devil is always in the detail…

By Arthur Brandwood | 03.30.2019
Regulatory affairs demand attention to detail. So when the European Medical Devices Coordination Group released document MDCG 2019-3 - Interpretation of Article 54(2)b we regulatory geeks just knew we should...
TrainXstation

Halfway there? Will the MDR/IVDR train arrive on time – and what about Brexit?

By Luis Jimenez | 12.03.2018
As the implementation journey for the EU MDR/IVDR passes the halfway point, we provide an update to the current state of play and the impact on our industry. Many, if...

Search

Recent Posts

TGA acceptance of international device reviews – clearing the fog

Dec 20, 2019

Brexit appears inevitable – and it seems UK MHRA will emulate New Zealand!

Dec 19, 2019

A single review program for medical devices?

Dec 2, 2019

The door to Europe is closed – so where else should I look?

Dec 2, 2019

Are Harmonised Standards facing irrelevance?

Nov 4, 2019

The question on clients’ lips… “How long will my application take?”

Nov 4, 2019

Categories

Categories

Archives

Archives

Archives

Tags

3D 3D printing 510(k) AIMD APAC Australia Biocompatibility Biomechanics Brexit CE CE Certificates clinical trials de novo distribution Europe FDA GHTF guidance Harmonization IMDRF IVD IVDD IVDR MDD MDR MDSAP medical device medical devices medicines New Zealand Notified Bodies PMA PMDA postmarket private health insurance QMS Quality Systems Reform Reimbursement SaMD Software standards Sterilisation TGA UDI
Translate »